Draegerwerk AG & Co KGaA
XETRA:DRW8

Watchlist Manager
Draegerwerk AG & Co KGaA Logo
Draegerwerk AG & Co KGaA
XETRA:DRW8
Watchlist
Price: 60.2 EUR -1.31%
Market Cap: 1.1B EUR

Draegerwerk AG & Co KGaA
Investor Relations

Draegerwerk AG & Co KGaA is a DE-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Luebeck, Schleswig-Holstein and currently employs 15,900 full-time employees. Draegerwerk AG & Co KGaA is a Germany-based provider of medical and safety technology. The firm operates through two segments: Medical and Safety. The Medical segment develops, produces and markets system solutions, equipment and services for the optimization of processes at the acute point of care, such as emergency care, preoperative care, critical care and prenatal care. The Safety segment develops, produces and markets products, system solutions and services for personal protection, gas detection technology and integrated hazard management for customers from various industries, such as mining, fire departments, police and disaster protection. The firm has production sites in Europe, the Americas, Africa and Asia.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q3 2025
Call Date
Oct 29, 2025
AI Summary
Q3 2025

Strong Q3: Dräger delivered a strong third quarter with significant net sales and EBIT growth, more than doubling EBIT compared to the prior year quarter.

Guidance Upgraded: The company now expects both net sales growth and EBIT margin to be in the upper half of its previous guidance range for the full year.

Order Momentum: Order intake rose by 9% in the first 9 months, reaching EUR 2.6 billion, the highest level since the pandemic-driven record year of 2020.

Margin Expansion: Gross margin improved by 0.7 percentage points to 45.1%, and EBIT margin in Q3 jumped to 6.8%.

Cash Flow: Operating cash flow increased by more than EUR 35 million to around EUR 93 million for the first 9 months.

Market Share: Management believes Dräger has captured its fair share in the ventilator market after key competitors exited, and expects continued growth opportunities.

Geographic Trends: Strong growth in Americas and EMEA offset weaker performance in China and Germany.

Cautious on Q4 Margins: Management expects Q4 margins to normalize and possibly decline slightly from Q3's exceptionally strong level.

Key Financials
Order Intake
EUR 2.6 billion
Net Sales
EUR 2.3 billion
EBIT
EUR 77 million (9M); EUR 57 million (Q3)
EBIT Margin
6.8% (Q3); 3% (9M)
Gross Margin
45.1%
Operating Cash Flow
EUR 93 million (9M)
Free Cash Flow
EUR 17 million (9M)
Net Financial Debt to EBITDA
0.7x
Return on Capital Employed (ROCE)
12%
Equity Ratio
nearly 50%
Other Earnings Calls

Management

Mr. Stefan A. Drager B.A.
Chairman of the Executive Board - Drägerwerk Verwaltungs AG
No Bio Available
Mr. Gert-Hartwig Lescow
CFO, Executive Board Member for IT & Vice Chairman of Executive Board - Drägerwerk Verwaltungs AG
No Bio Available
Mr. Anton Schrofner
Executive Board Member for Medical Division - Drägerwerk Verwaltungs AG
No Bio Available
Mr. Rainer Klug
Executive Board Member for Safety Division - Drägerwerk Verwaltungs AG
No Bio Available
Dr. Reiner Piske
Executive Board Member for Sales & Human Resources - Drägerwerk Verwaltungs AG
No Bio Available
Mr. Thomas Fischler
Head of Treasury & Investor Relations
No Bio Available
Mr. Welf Böttcher
Head of Corporate Communications
No Bio Available

Contacts

Address
SCHLESWIG-HOLSTEIN
Luebeck
Moislinger Allee 53-55
Contacts
+494518820.0
www.draeger.com